Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
SNOA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.44%69.045.6%$170.86m
CTLTCatalent, Inc. -5.16%94.652.1%$113.40m
VRXValeant Pharmaceuticals International, Inc. -0.34%19.2514.1%$113.27m
BHCBausch Health Cos., Inc. -0.34%19.250.0%$83.35m
JAZZJazz Pharmaceuticals Plc -1.03%142.832.4%$78.28m
GWPHGW Pharmaceuticals Plc 3.10%129.336.1%$67.70m
UTHRUnited Therapeutics Corp. -1.70%135.4314.1%$63.17m
PRGOPerrigo Co. Plc 1.89%48.656.8%$55.66m
SAGESAGE Therapeutics, Inc. 2.45%79.888.6%$42.39m
ARGXargenx SE -2.50%262.280.0%$37.95m
ICLRICON plc -0.77%186.374.2%$37.35m
SAVACassava Sciences, Inc. 2.11%7.250.0%$34.20m
AMRNAmarin Corp. Plc 0.45%4.481.5%$32.90m
PCRXPacira Biosciences, Inc. 0.56%64.2810.0%$31.75m
CORTCorcept Therapeutics, Inc. -0.52%22.885.4%$31.63m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.